(marketscreener.com) FRAMINGHAM, Mass., July 14, 2021 /PRNewswire/ -- BERG, a clinical-stage biotech that employs patient biology and artificial intelligence to research diseases and develop innovative treatments, will present two poster presentations at the Society for Neuro-Oncology: Basic and Translational Omics of Brain Tumors and Their Microenvironment...https://www.marketscreener.com/news/latest/BERG-To-Present-Latest-Glioblastoma-GBM-Treatment-Data-At-Society-For-Neuro-Onocology-2021-Meeting--35858643/?utm_medium=RSS&utm_content=20210714
BERG is a Massachusetts-based biotechnology company that offers solutions such as AI-powered drug discovery and research for industries including healthcare and pharmaceuticals.